Literature DB >> 15359725

Tumor suppressor gene 14-3-3sigma is down-regulated whereas the proto-oncogene translation elongation factor 1delta is up-regulated in non-small cell lung cancers as identified by proteomic profiling.

Yang Liu1, Qun Chen, Jian-Ting Zhang.   

Abstract

Lung cancer, a leading cause of cancer deaths, consists of two major groups: small cell lung cancer (SCLC) and nonsmall cell lung cancer (NSCLC) with the NSCLC accounting for approximately 75% cases of lung cancers. It has been suggested that molecular changes including overexpression of oncogenes and decreased expression of tumor suppressor genes are responsible for lung carcinogenesis. In this study, we analyzed protein profiles of four different human NSCLC cell lines compared with normal human bronchial epithelial cells using two-dimensional PAGE and MALDI-TOF mass spectrometry. We identified 12 protein spots with different expressions between the normal and cancer cells. Of these proteins, vimentin, cytokeratin 8, YB-1, PCNA, Nm23, hnRNP A2/B1, and HSP90beta were known to be up-regulated in lung cancers, which is consistent with the current study. We also found that the expression of M-type pyruvate kinase is altered in NSCLC likely due to changes in translational control and/or differential phosphorylation of the protein. Interestingly, the expression of the tumor suppressor gene 14-3-3sigma is down-regulated while that of the proto-oncogene TEF1delta is up-regulated in NSCLC cells. On the basis of these observations and previous studies, we propose that the altered expression of 14-3-3sigma and TEF1delta may be involved in lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15359725     DOI: 10.1021/pr034127+

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  23 in total

1.  Eukaryotic translation elongation factor 1 delta inhibits the ubiquitin ligase activity of SIAH-1.

Authors:  Huiling Wu; Yan Shi; Ying Lin; Wei Qian; Yao Yu; Keke Huo
Journal:  Mol Cell Biochem       Date:  2011-06-03       Impact factor: 3.396

2.  Human ABCC1 interacts and colocalizes with ATP synthase α, revealed by interactive proteomics analysis.

Authors:  Youyun Yang; Zhaomin Li; Wei Mo; Raghuram Ambadipudi; Randy J Arnold; Petra Hrncirova; Milos V Novotny; Elias Georges; Jian-Ting Zhang
Journal:  J Proteome Res       Date:  2012-01-18       Impact factor: 4.466

3.  14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.

Authors:  Yifan Chen; Zhaomin Li; Zizheng Dong; Jenny Beebe; Ke Yang; Liwu Fu; Jian-Ting Zhang
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

4.  Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics.

Authors:  Alexandre Dos Santos; Magali Court; Valérie Thiers; Sokhavuth Sar; Catherine Guettier; Didier Samuel; Christian Bréchot; Jérôme Garin; France Demaugre; Christophe D Masselon
Journal:  Mol Cell Proteomics       Date:  2010-05-31       Impact factor: 5.911

5.  Applications of CRISPR/Cas technology against drug-resistant lung cancers: an update.

Authors:  Mayank Chaudhary; Pooja Sharma; Tapan Kumar Mukherjee
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

6.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

7.  Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.

Authors:  Zhaomin Li; Zizheng Dong; David Myer; Michele Yip-Schneider; Jianguo Liu; Ping Cui; C Max Schmidt; Jian-Ting Zhang
Journal:  BMC Cancer       Date:  2010-11-01       Impact factor: 4.430

8.  Evaluation of 14-3-3 sigma as a potential partner of p16 in quiescence and differentiation.

Authors:  Payal Agarwal; Patricia DeInnocentes; R Curtis Bird
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-30       Impact factor: 2.416

9.  Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.

Authors:  Nam K Yoon; David B Seligson; David Chia; Yahya Elshimali; Giri Sulur; Ai Li; Steve Horvath; Erin Maresh; Vei Mah; Shikha Bose; Benjamin Bonavida; Lee Goodglick
Journal:  Cancer Biomark       Date:  2009       Impact factor: 4.388

10.  Differential tissue-specific protein markers of vaginal carcinoma.

Authors:  K Hellman; A A Alaiya; S Becker; M Lomnytska; K Schedvins; W Steinberg; A-C Hellström; S Andersson; U Hellman; G Auer
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.